# US 2026/0242370 A1 · Flow chemistry process for preparing aza-bicyclic heteroaryl compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0242370 A1
- Document ID: US20260242370A1
- Status: Published application
- Kind: A1
- Application number: 19/161,127
- Filed: 2024-03-01
- Published: 2026-08-20
- Earliest claimed: 2023-03-02
- Assignees: Actinogen Medical Limited
- Applicants: Actinogen Medical Limited
- Inventors: Jason Douglas WILLIAMS; Michael PRIESCHL
- Web page: https://patentgrep.com/patent/US20260242370A1

## CPC

- B01J 19/0093: {Microreactors, e.g. miniaturised or microfabricated reactors (laboratory containers with capillary fluid transport in microfabricated channels or chambers B01L3/5027)}
- C07D 451/06: Oxygen atoms
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present disclosure relates to a continuous flow process for synthesis of heterocyclic methanone compounds, and in particular 3-substituted, 3-hydroxyl-(8-aza-bicyclo[3.2.1]oct-8-yl)-[5-(1h-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds, and aza-bicyclo intermediates thereof. In particular, the present disclosure also relates to a continuous flow process that can be utilised toward the synthesis of Xanamem.

## Claims

### Claim 1

A continuous flow process for preparing an aza-bicyclic compound of Formula 1, or salt thereof:
comprising an organolithium reaction of a nortropinone compound of Formula 2:
with a halogenated compound of Formula 3:
in the presence of an organolithium reagent;
wherein
R1 is a monocyclic or bicyclic heteroaryl group each unsubstituted or substituted with one or more substituents selected from the group consisting of halogen, —C1-6alkyl, —O—C1-6alkyl, —C1-6haloalkyl, and —O—C1-6haloalkyl;
R2 is an amine protecting group; and
X is a halogen.

### Claim 2 (depends on 1)

The continuous flow process of claim 1, wherein the continuous flow process comprises the nortropinone compound of Formula 2, the halogenated compound of Formula 3, and the organolithium reagent, in one or more continuous flow streams, in a continuous flow reactor configured at a temperature effective for synthesising the aza-bicylic compound of Formula 1, or salt thereof.

### Claim 3 (depends on 1, 2)

The continuous flow process of claim 1 or claim 2, wherein the nortropinone compound of Formula 2 and the halogenated compound of Formula 3 are initially combined.

### Claim 4 (depends on 1, 2, 3)

The continuous flow process of any one of claims 1 to 3, wherein a combination of the nortropinone compound of Formula 2 and the halogenated compound of Formula 3, is subsequently combined with the organolithium reagent.

### Claim 5 (depends on 1, 2, 3, 4)

The continuous flow process of any one of claims 1 to 4, wherein the process comprises:
combining a continuous flow stream comprising the compound of Formula 2 and the compound of Formula 3, with a continuous flow stream comprising the organolithium reagent, to obtain a continuous flow stream comprising an aza-bicyclic compound of Formula 1, or salt thereof.

### Claim 6 (depends on 1, 2, 3, 4, 5)

The continuous flow process of any one of claims 1 to 5, wherein the process comprises:
combining a continuous flow stream comprising the compound of Formula 2 with a continuous flow stream comprising the compound of Formula 3, to obtain a continuous flow stream comprising the compound of Formula 2 and the compound of Formula 3; and
combining the continuous flow stream comprising the compound of Formula 2 and the compound of Formula 3, with a continuous flow stream comprising the organolithium reagent, to obtain a continuous flow stream comprising an aza-bicyclic compound of Formula 1, or salt thereof.

### Claim 7 (depends on 1, 2)

The continuous flow process of claim 1 or claim 2, wherein the process comprises:
combining a continuous flow stream comprising a compound of Formula 3 with a continuous flow stream comprising an organolithium reagent, to obtain a continuous flow stream comprising an organolithium reaction intermediate; and
combining the continuous flow stream comprising the organolithium reaction intermediate with a continuous flow stream comprising a compound of Formula 2, to obtain a continuous flow stream comprising an aza-bicyclic compound of Formula 1, or salt thereof.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The continuous flow process of any one of claims 1 to 7, wherein the continuous flow process further comprises:
combining the aza-bicyclic compound of Formula 1, or salt thereof, with a quenching solution.

### Claim 9 (depends on 8)

The continuous flow process of claim 8, wherein the quenching solution is selected from the group consisting of: a polar protic solvent, a non-polar protic solvent, an aqueous solvent, an alcohol, and an acid, or a combination thereof.

### Claim 10 (depends on 8, 9)

The continuous flow process of claim 8 or claim 9, wherein the process comprises:
combining a continuous flow stream comprising the aza-bicyclic compond of Formula 1, or salt thereof, with a continuous flow stream comprising the quenching solution, to obtain a continuous flow stream comprising the aza-bicyclic compound of Formula 1.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The continuous flow process of any one of claims 1 to 10, wherein the continuous flow process further comprises:
combining a continuous flow stream comprising a solvent with a continuous flow stream comprising the organolithium reagent, to controllably dilute the concentration of the organolithium reagent.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The continuous flow process of any one of claims 1 to 11, wherein the continuous flow process further comprises:
preparing a salt of an amine bicyclic compound of Formula 4:
wherein the process comprises reacting a compound of Formula 1 with an acid to remove the amine protecting group, to obtain a salt of the compound of Formula 4.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The continuous flow process of any one of claims 1 to 12, wherein the continuous flow process further comprises:
preparing a heterocyclic methanone compound of Formula 5:
wherein the process comprises reacting a carboxylic acid compound of Formula 6, or a salt thereof:
with the amine bicyclic compound of Formula 4, or salt thereof, in the presence of at least one coupling reagent, to obtain the heterocyclic methanone compound of Formula 5.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The continuous flow process of any one of claims 1 to 13, wherein the organolithium reagent is selected from any compound containing a carbon-lithium bond or a carbon-magnesium-lithium bond.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The continuous flow process of any one of claims 1 to 14, wherein the organolithium reagent is selected from the group consisting of: alkyl lithium, alkenyl lithium, alkynyl lithium, aralkyl lithium, aryl lithium, heteroaryl lithium, alkyllithium magnesium complexes, and any lithium halide complexes thereof.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The continuous flow process of any one of claims 1 to 15, wherein the organolithium reagent is selected from the group consisting of: methyllithium, ethyllithium, propyllithium, butyllithium, pentyllithium, hexyllithium, methoxymethyllithium, ethoxymethyllithium, vinyllithium, allyllithium, propenyllithium, butenyllithium, ethynyllithium, butynyllithium, pentynyllithium, hexynyllithium, benzyllithium, phenylethyllithium, phenyllithium, naphthyllithium, 2-thienyllithium, 4-pyridyllithium, 2-quinolyllithium, tri(n-butyl)magnesiumlithium and trimethylmagnesiumlithium, (trimethylsilyl)methyllithium, lithium(trimethylsilyl) acetylide, lithium acetylide, lithium phenylacetylide, cyclopentadienyllithium, lithium pentamethylcyclopentadienide, lithium methide, and any lithium halide complexes thereof.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

The continuous flow process of any one of claims 1 to 16, wherein the organolithium reagent is selected from the group consisting of: methyllithium or any lithium halide complexes thereof.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The continuous flow process of any one of claims 1 to 17, wherein the amount of the organolithium reagent relative to the amount of the halogenated compound of Formula 3 is provided in a Molar ratio of between about 0.1 to about 10.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)

The continuous flow process of any one of claims 1 to 18, wherein the concentration of the organolithium reagent is at least about 0.1 mol/L.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)

The continuous flow process of any one of claims 1 to 19, wherein the one or more continuous flow streams each has a flow rate of at least about 0.5 mL/min.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)

The continuous flow process of any one of claims 1 to 20, wherein the amount of the nortropinone compound of Formula 2 relative to the amount of the halogenated compound of Formula 3, is provided in a Molar ratio of between about 0.1 to about 10.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)

The continuous flow process of any one of claims 1 to 21, wherein the residence time between obtaining the continuous flow stream comprising the organolithium reaction intermediate and obtaining a continuous flow stream comprising the aza-bicyclic compound of Formula 1, or salt thereof, is at least 0.01 seconds.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The continuous flow process of any one of claims 1 to 22, wherein the process is performed at a temperature of less than 20° C., less than 10° C., less than 0° C., less than −10° C., less than −20° C., less than −30° C., less than −40° C., less than −50° C., less than −60° C., less than −70° C., or less than −80° C.

### Claim 24 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23)

The continuous flow process of any one of claims 1 to 23, wherein the two or more continuous flow streams are provided as solutions comprising at least one solvent independently selected from the group consisting of: tetrahydrofuran, methyl tetrahydrofuran, diethyl ether, methyl tert-butyl ether, cyclopentyl methyl ether, toluene, and combinations thereof.

### Claim 25 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The continuous flow process of any one of claims 1 to 24, wherein the process provides the aza-bicylic compound of Formula 1 in a yield of at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, or at least 90%, as determined from a compound of Formula 2 or a compound of Formula 3 starting material.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The continuous flow process of any one of claims 1 to 25, wherein the process provides a conversion of the nortropinone compound of Formula 2, or of the halogenated compound of Formula 3, to an aza-bicyclic compound of Formula 1, or salt thereof, of at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, or at least 90%, as measured by HPLC.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The continuous flow process of any one of claims 1 to 26, wherein the process provides the aza-bicylic compound of Formula 1 in at least 70%, at least 80%, at least 90%, or at least 95% purity, as determined by HPLC.

### Claim 28 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)

The continuous flow process of any one of claims 1 to 27, wherein the process takes place in a reactor of a type selected from the group consisting of: continuous flow reactor; microreactor; continuous tubular reactor; laminar flow reactor; flow reactor; static mixing elements; continuous stirred tank reactor; and semibatch reactor.
